These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2696620)
1. Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents. Pfaller MA; Gerarden T Diagn Microbiol Infect Dis; 1989; 12(6):467-71. PubMed ID: 2696620 [TBL] [Abstract][Full Text] [Related]
2. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans. Pfaller MA; Riley J; Koerner T Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of PASCO and national committee for clinical laboratory standards M27-A broth microdilution methods for antifungal drug susceptibility testing of yeasts. Arthington-Skaggs BA; Motley M; Warnock DW; Morrison CJ J Clin Microbiol; 2000 Jun; 38(6):2254-60. PubMed ID: 10834985 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of clinical yeast isolates to fluconazole and terconazole. Cooper CR; McGinnis MR Am J Obstet Gynecol; 1996 Dec; 175(6):1626-31. PubMed ID: 8987951 [TBL] [Abstract][Full Text] [Related]
5. The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats. Van Cutsem J Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 2):1200-6. PubMed ID: 1951575 [TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of 14 alpha-desmethyl sterol synthesis in Candida albicans by terconazole, a new triazole antimycotic. Isaacson DM; Tolman EL; Tobia AJ; Rosenthale ME; McGuire JL; Vanden Bossche H; Janssen PA J Antimicrob Chemother; 1988 Mar; 21(3):333-43. PubMed ID: 3129389 [TBL] [Abstract][Full Text] [Related]
7. Anticandidal activities of terconazole, a broad-spectrum antimycotic. Tolman EL; Isaacson DM; Rosenthale ME; McGuire JL; Van Cutsem J; Borgers M; Van den Bossche H Antimicrob Agents Chemother; 1986 Jun; 29(6):986-91. PubMed ID: 3729366 [TBL] [Abstract][Full Text] [Related]
8. Reduced Antifungal Susceptibility of Vulvovaginal Candida Species at Normal Vaginal pH Levels: Clinical Implications. Spitzer M; Wiederhold NP J Low Genit Tract Dis; 2018 Apr; 22(2):152-158. PubMed ID: 29474241 [TBL] [Abstract][Full Text] [Related]
9. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy]. Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361 [TBL] [Abstract][Full Text] [Related]
10. In vitro studies with terconazole. Isaacson DM; Foleno B; Tolman EL; Rosenthale ME Gynakol Rundsch; 1985; 25 Suppl 1():12-25. PubMed ID: 3891537 [No Abstract] [Full Text] [Related]
11. Antifungal relative inhibition factors: BAY l-9139, bifonazole, butoconazole, isoconazole, itraconazole (R 51211), oxiconazole, Ro 14-4767/002, sulconazole, terconazole and vibunazole (BAY n-7133) compared in vitro with nine established antifungal agents. Odds FC; Webster CE; Abbott AB J Antimicrob Chemother; 1984 Aug; 14(2):105-14. PubMed ID: 6094418 [TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. Choukri F; Benderdouche M; Sednaoui P J Mycol Med; 2014 Dec; 24(4):303-7. PubMed ID: 25442913 [TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of oral Candida to seven antifungal agents. Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594 [TBL] [Abstract][Full Text] [Related]
14. [Identification and in vitro antifungal susceptibility of vaginal Candida spp. isolates to fluconazole, clotrimazole and nystatin]. Diaz MC; Camponovo R; Araya I; Cerda A; Santander MP; Carrillo-Muñoz AJ Rev Esp Quimioter; 2016 Jun; 29(3):151-4. PubMed ID: 27167765 [TBL] [Abstract][Full Text] [Related]
15. [Antifungal susceptibility among the isolates of yeast from the University Hospital of the Ryukyus]. Ohta C; Yamane N; Nakasone I; Onaga S; Nakamura K Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2005; 16(2):127-33. PubMed ID: 16536058 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp. Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898 [TBL] [Abstract][Full Text] [Related]
17. Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp. Sims CR; Paetznick VL; Rodriguez JR; Chen E; Ostrosky-Zeichner L J Clin Microbiol; 2006 Jun; 44(6):2105-8. PubMed ID: 16757605 [TBL] [Abstract][Full Text] [Related]
18. The action of miconazole of the growth of Candida albicans. Van Den Bossche H; Willemsens G; Van Cutsem JM Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999 [TBL] [Abstract][Full Text] [Related]
19. [Susceptibility to miconazole and itraconazole of Candida strains isolated from hospitalized and outpatient clinic patients]. Kurnatowska AK; Kwaśniewska J Wiad Parazytol; 2009; 55(4):415-23. PubMed ID: 20209818 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method. Pfaller MA; Hata K; Jones RN; Messer SA; Moet GJ; Castanheira M Diagn Microbiol Infect Dis; 2011 Oct; 71(2):167-70. PubMed ID: 21696907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]